Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

235 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Lipid lowering: new agents and new concepts].
Brandts J, Verket M, Müller-Wieland D. Brandts J, et al. Herz. 2022 Oct;47(5):419-425. doi: 10.1007/s00059-022-05133-7. Epub 2022 Aug 26. Herz. 2022. PMID: 36018378 Review. German.
Design and rationale of the ODYSSEY DM-DYSLIPIDEMIA trial: lipid-lowering efficacy and safety of alirocumab in individuals with type 2 diabetes and mixed dyslipidaemia at high cardiovascular risk.
Müller-Wieland D, Leiter LA, Cariou B, Letierce A, Colhoun HM, Del Prato S, Henry RR, Tinahones FJ, Aurand L, Maroni J, Ray KK, Bujas-Bobanovic M. Müller-Wieland D, et al. Cardiovasc Diabetol. 2017 May 25;16(1):70. doi: 10.1186/s12933-017-0552-4. Cardiovasc Diabetol. 2017. PMID: 28545518 Free PMC article. Clinical Trial.
Artificial intelligence supported patient self-care in chronic heart failure: a paradigm shift from reactive to predictive, preventive and personalised care.
Barrett M, Boyne J, Brandts J, Brunner-La Rocca HP, De Maesschalck L, De Wit K, Dixon L, Eurlings C, Fitzsimons D, Golubnitschaja O, Hageman A, Heemskerk F, Hintzen A, Helms TM, Hill L, Hoedemakers T, Marx N, McDonald K, Mertens M, Müller-Wieland D, Palant A, Piesk J, Pomazanskyi A, Ramaekers J, Ruff P, Schütt K, Shekhawat Y, Ski CF, Thompson DR, Tsirkin A, van der Mierden K, Watson C, Zippel-Schultz B. Barrett M, et al. EPMA J. 2019 Nov 22;10(4):445-464. doi: 10.1007/s13167-019-00188-9. eCollection 2019 Dec. EPMA J. 2019. PMID: 31832118 Free PMC article. Review.
[New oral antidiabetic drugs].
Müller-Wieland D, Schütt K, Brandts J, Marx N. Müller-Wieland D, et al. Herz. 2020 Aug;45(5):493-503. doi: 10.1007/s00059-020-04946-8. Herz. 2020. PMID: 32601754 German.
Glycaemic Control in Diabetes.
Müller-Wieland D, Brandts J, Verket M, Marx N, Schütt K. Müller-Wieland D, et al. Handb Exp Pharmacol. 2022;270:47-71. doi: 10.1007/164_2021_537. Handb Exp Pharmacol. 2022. PMID: 34467427
[Pathophysiological principles of dyslipoproteinaemia].
Müller-Wieland D, Merkel M, Verket M, März W, von Eckardstein A. Müller-Wieland D, et al. Dtsch Med Wochenschr. 2021 Nov;146(22):e103-e111. doi: 10.1055/a-1516-2441. Epub 2021 Nov 3. Dtsch Med Wochenschr. 2021. PMID: 34731902 Review. German.
235 results